Multivariate calibration and modeling of UV-VIS spectra of guest-host complexes for the determination of the enantiomeric ratio of propranolol

Farmacia

Volumn 61, Issue 1, 2013, Pages 79-87

  Iacob, Bogdan Cezar ^a   Tiuca, Ioana ^a   Bodok, Ede ^a   Oprean, Radu ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

cyclodextrin; Chiral analysis; Multivariate regression; Propranolol

Indexed keywords

BETA CYCLODEXTRIN; PROPRANOLOL;

ARTICLE; CALIBRATION; CAPILLARY ELECTROPHORESIS; CHEMOMETRICS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LATENT STRUCTURE ANALYSIS; MATHEMATICAL MODEL; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 84874082188     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Food & Drug Administration. FDA's policy statement for the development of new stereoisomeric drugs, 57 Fed. Reg., 1992, 22249.
2. McConathy J, Owens MJ. Stereochemistry in drug action, J. Clin. Psychiatry, 2003, 5, 70-3.
3. Agustiana J, Kamaruddina AH, Bhatiaa S. Single enantiomeric β-blockers-The existing technologies, Process Biochemistry, 2010, 45:1587-1604.
4. Subramanian G. Chiral Separation Techniques. 3rd Edition. Imran Ali and Hassan Y. Aboul- Enein, Role of Polysaccharides in Chiral Separations by Liquid Chromatography and Capillary Electrophoresis, Wiley-VCH, Weinheim, 2007.
5. Blaschke G, Kraft HP, Fickentscher K, Köhler F., Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers, Drug Res., 1979, 29, 1640-1642.
6. Knoche B., Blaschke G., Investigations on the in vitro racemization of thalidomide by highperformance liquid chromatography, J. Chromatogr. A, 1994, 666(1-2), 235-240.
7. Beesley TE, Scott RPW. Chiral Chromatography, John Wiley & Sons Ltd, Chichester, 1998.
8. Goyal RN, Gupta RK, Oyama M, Bachheti N. Differential pulse voltammetric determination of atenolol in pharmaceutical formulations and urine using nanogold modified indium tin oxide electrode. Electrochem. Comm., 2006, 8, 65-70.
9. Black SB, Stenhouse AM, Hanson RC, Solid-phase extraction and derivatisation methods for β-blockers in human post mortem whole blood, urine and equine urine, J. Pharm. Biomed. Anal., 1996, 685, 67-80.
10. Toyooka T., Torium M., Ishi Y., Enantioseparation of β-blockers labelled with a chiral fluorescent reagent, R(-)-DBD-PyNCS, by reversed-phase liquid chromatography, J. Pharm. Biomed. Anal., 1997, 15(9-10), 1467-1476.
11. Fakayode SO, Busch MA, Busch KW. Determination of enantiomeric composition of samples by multivariate regression modeling of spectral data obtained with cyclodextrin guest-host complexes-Effect of an achiral surfactant and use of mixed cyclodextrins, Talanta 2006, 68, 1574-1583.
12. K.W. Busch, I.M. Swamidoss, S.O. Fakayode, M.A. Busch, Determination of the Enantiomeric Composition of Guest Molecules by Chemometric Analysis of the UV-Visible Spectra of Cyclodextrin Guest-Host Complexes, J. Am. Chem. Soc., 2003, 125, 1690-1.
13. K.W. Busch, I.M. Swamidoss, S.O. Fakayode, M.A. Busch, Determination of the enantiomeric composition of some molecules of pharmaceutical interest by chemometric analysis of the UV spectra of cyclodextrin guest-host complexes, Anal. Chimica Acta, 2004, 525, 53-62.
14. S.O. Fakayode, I.M. Swamidoss, M.A. Busch, K.W. Busch, Determination of the enantiomeric composition of some molecules of pharmaceutical interest by chemometric analysis of the UV spectra of guest-host complexes formed with modified cyclodextrins, Talanta, 2005, 65, 838-45.
15. S.O. Fakayode, M.A. Busch, K.W. Busch, Determination of the enantiomeric composition of phenylalanine samples by chemometric analysis of the fluorescence spectra of cyclodextrin guest-host complexes, Analyst, 2005, 130, 233-41.
16. Wang Y, Zhang F, Liang J, Li H, Kong J. A novel strategy for the determination of enantiomeric compositions of chiral compounds by chemometric analysis of the UV-vis spectra of bovine serum albumin receptor-ligand mixtures. Spectrochimica Acta Part A, 2007, 68, 279-283.
17. Kennedy HL. Current utilisation trends for beta blockers in cardiovascular disease, Am. J. Med., 2001, 110(5A), 2S-6S.
18. Mehvar R, Brocks DR., Stereospecific pharmacokinetics and pharmacodynamics of betaadrenergic blockers in humans. J. Pharm. Sci. 2001, 4(2), 185-200.
19. Walle T, Web JG, Bagwel EE, Wale UK, Daniel HB, Gaffney TE. Stereoselective delivery and actions of beta receptor antagonist. Biochem. Pharmacol., 1988, 37, 115-24.
20. Armstrong DW, Ward TJ, Armstrong RD, Beesley TE. Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes, Science 1986, 232(4754), 1132-5.
21. Wren SA, Rowe RC. Theoretical aspects of chiral separation in capillary electrophoresis. III. Application to beta-blockers. J Chromatogr., 1993, 635(1), 113-8.
22. Quang C, Khalidi MG., Direct Separation of the Enantiomers of b-Blockers by Cyclodextrin- Mediated Capillary Zone Electrophoresis, J. High Res. Chromatogr., 1994, 17, 99-101